Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;42(5):152-157.
doi: 10.18773/austprescr.2019.052. Epub 2019 Oct 1.

Stopping and switching antipsychotic drugs

Affiliations
Review

Stopping and switching antipsychotic drugs

Nicholas Keks et al. Aust Prescr. 2019 Oct.

Abstract

In general, specialist advice should be sought when stopping or switching antipsychotics While antipsychotics are often needed long term, there are circumstances when clinicians, patients and families should reconsider the benefits versus the harms of continuing treatment Withdrawal syndromes, relapse and rebound can occur if antipsychotics are discontinued, especially if they are stopped abruptly. Generally, they should be reduced and stopped slowly, ideally over weeks to months Relapse of psychosis and exacerbation occur in most patients with psychotic disorders, occasionally with drastic consequences. Sometimes this occurs many months after stopping antipsychotics Switching from one antipsychotic to another is frequently indicated due to an inadequate treatment response or unacceptable adverse effects. It should be carried out cautiously and under close observation

Keywords: antipsychotics; drug withdrawal syndrome; psychosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none declared

References

    1. Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. 10.1016/S0140-6736(13)60733-3 - DOI - PubMed
    1. Mitchell PB. Bipolar disorder. Aust Fam Physician 2013;42:616-9. - PubMed
    1. Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-36. 10.1002/wps.20204 - DOI - PMC - PubMed
    1. Stevenson E, Schembri F, Green DM, Burns JD. Serotonin syndrome associated with clozapine withdrawal. JAMA Neurol 2013;70:1054-5. 10.1001/jamaneurol.2013.95 - DOI - PubMed
    1. Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016;50:410-72. 10.1177/0004867416641195 - DOI - PubMed

LinkOut - more resources